EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The revolutionary weekly insulin: The prime time for icodec in Pakistan?

Fariha Khan, Arfa Ahmed Assad

Journal of the Pakistan Medical Association · 01.11.2026 · 76 (11) · 1983-1983

DOI: 10.47391/jpma.41220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 01.11.2026. Verfasst von Fariha Khan und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, The burden of diabetes in Pakistan is reaching alarming levels, with prevalence rising from 5.2 million in 2000 to around 33 million in 2021, a striking sixfold increase over two decades. (1) Insulin remains the mainstay of treatment for type 1 diabetes mellitus and a significant and growing component in the management of type 2 diabetes mellitus. Despite its clinical necessity, initiation and adherence to insulin therapy are frequently delayed due to multiple barriers, including fear of injections, multiple daily dosing, social stigma, and disruption to quality of life. In Pakistan, these challenges are further amplified by low health literacy, cultural misconceptions regarding insulin, dependence on cold-chain storage, and a resource-constrained healthcare system. (1, 2) Insulin icodec is a recently approved once-weekly ultra-long-acting basal insulin with a half-life of about 196 hours, reducing injection frequency from 365 to 52 per year. (3) It has shown superior glycaemic control to other long acting insulin, as the ONWARDS 3 trial demonstrated a statistically significant greater reduction in glycated haemoglobin (-0.19%) with insulin icodec compared to insulin glargine in insulin-naïve patients with type 2 diabetes mellitus, with a similar safety profile. (4) A meta-analysis of the ONWARDS 1–5 trials reported a higher proportion of patients achieving target glycated haemoglobin levels (

Zitieren

APA

Khan, F., & Assad, A. A. (2026). The revolutionary weekly insulin: The prime time for icodec in Pakistan?. Journal of the Pakistan Medical Association, 76(11), 1983-1983. https://doi.org/10.47391/jpma.41220

Vancouver

Khan F, Assad AA. The revolutionary weekly insulin: The prime time for icodec in Pakistan?. Journal of the Pakistan Medical Association. 2026;76(11):1983-1983. doi:10.47391/jpma.41220

BibTeX
@article{Khan2026,
  author = {Khan, Fariha and Assad, Arfa Ahmed},
  title = {The revolutionary weekly insulin: The prime time for icodec in Pakistan?},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  volume = {76},
  number = {11},
  pages = {1983--1983},
  doi = {10.47391/jpma.41220}
}
Kostenlos starten →